381 related articles for article (PubMed ID: 25410753)
1. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
Li W; Tan J; Wang P; Li N; Li C
Mol Cell Biochem; 2015 Jan; 399(1-2):279-89. PubMed ID: 25410753
[TBL] [Abstract][Full Text] [Related]
2. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
Li W; Tan J; Wang P; Wu P
Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
Tan J; Li W; Wang P
Chin J Cancer; 2011 Aug; 30(8):574-80. PubMed ID: 21801606
[TBL] [Abstract][Full Text] [Related]
4. The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma.
Li W; Tan J; Wang P; Li N; Zhang F
Oncol Lett; 2013 Feb; 5(2):669-674. PubMed ID: 23420532
[TBL] [Abstract][Full Text] [Related]
5. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
Kim SH; Chung HK; Kang JH; Kim KI; Jeon YH; Jin YN; Yun CO; Chung JK
Hum Gene Ther; 2008 Sep; 19(9):951-7. PubMed ID: 18810799
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
[TBL] [Abstract][Full Text] [Related]
8. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.
Trujillo MA; Oneal MJ; Davydova J; Bergert E; Yamamoto M; Morris JC
Breast Cancer Res; 2009; 11(4):R53. PubMed ID: 19635153
[TBL] [Abstract][Full Text] [Related]
9. [Transfer of sodium iodide symporter gene into glioma cells by recombinant adenovirus and radioiodine therapy for the glioma cells in vitro and in nude mice].
Li W; Tan J; Zheng W; Li N
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):101-4. PubMed ID: 21575476
[TBL] [Abstract][Full Text] [Related]
10. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
11. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
12. Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter.
Huang R; Zhao Z; Ma X; Li S; Gong R; Kuang A
Cancer Gene Ther; 2011 Feb; 18(2):144-52. PubMed ID: 21037556
[TBL] [Abstract][Full Text] [Related]
13. Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.
Zhang M; Shi S; Guo R; Miao Y; Li B
Oncol Rep; 2016 Oct; 36(4):2289-97. PubMed ID: 27573304
[TBL] [Abstract][Full Text] [Related]
14. Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model.
Ahn SJ; Jeon YH; Lee YJ; Lee YL; Lee SW; Ahn BC; Ha JH; Lee J
Cancer Gene Ther; 2010 Jul; 17(7):492-500. PubMed ID: 20186172
[TBL] [Abstract][Full Text] [Related]
15. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated and tumor-specific transgene expression of the sodium-iodide symporter from the human telomerase reverse transcriptase promoter enhances killing of lung cancer cell line in vitro.
Shi YZ; Zhang J; Liu ZL; Du SY; Shen YM
Chin Med J (Engl); 2010 Aug; 123(15):2070-6. PubMed ID: 20819544
[TBL] [Abstract][Full Text] [Related]
17. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
Tang J; Wang X; Xu Y; Shi Y; Liu Z; Yang Y
Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
19. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
20. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
Irving J; Wang Z; Powell S; O'Sullivan C; Mok M; Murphy B; Cardoza L; Lebkowski JS; Majumdar AS
Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
